Security National Trust’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding GYRE
NCM
SCM
O
OM
GTC
ACP
2L
Security National Trust's GYRE Position: Q1 2021 in Review
Security National Trust sold out of Gyre Therapeutics (GYRE) in Q1 2021, closing a stake of 62 shares — an estimated $3K sold.
Security National Trust first reported a position in GYRE in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 89 funds tracked by Wall St. Rank hold GYRE as of Q1 2021.
- Security National Trust reported no remaining Gyre Therapeutics position as of Q1 2021 after selling out during the quarter.
- Security National Trust sold 62 Gyre Therapeutics shares in Q1 2021, an estimated $3K.
- Security National Trust first reported a position in Gyre Therapeutics in Q4 2020 and held it in 1 quarter.
- Security National Trust's Gyre Therapeutics position peaked at $3K in Q4 2020.
- 89 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2021.
Based on Security National Trust's 13F filing for Q1 2021, filed 4 May 2021.